Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Bacitracin Zinc
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase IV
Sponsor : Healthpoint
Deal Size : Inapplicable
Deal Type : Inapplicable
Comparison of Wound Bed Establishment in Facial Burns
Details : Bacitracin is a Protein drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Burns.
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
August 17, 2012
Lead Product(s) : Bacitracin Zinc
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase IV
Sponsor : Healthpoint
Deal Size : Inapplicable
Deal Type : Inapplicable